Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

423 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Promise and Implementation of Proteomic Prostate Cancer Biomarkers.
Latosinska A, Frantzi M, Merseburger AS, Mischak H. Latosinska A, et al. Among authors: merseburger as. Diagnostics (Basel). 2018 Aug 29;8(3):57. doi: 10.3390/diagnostics8030057. Diagnostics (Basel). 2018. PMID: 30158500 Free PMC article. Review.
Discovery and validation of urinary biomarkers for detection of renal cell carcinoma.
Frantzi M, Metzger J, Banks RE, Husi H, Klein J, Dakna M, Mullen W, Cartledge JJ, Schanstra JP, Brand K, Kuczyk MA, Mischak H, Vlahou A, Theodorescu D, Merseburger AS. Frantzi M, et al. Among authors: merseburger as. J Proteomics. 2014 Feb 26;98:44-58. doi: 10.1016/j.jprot.2013.12.010. Epub 2013 Dec 25. J Proteomics. 2014. PMID: 24374379 Clinical Trial.
Protein interactome of muscle invasive bladder cancer.
Bhat A, Heinzel A, Mayer B, Perco P, Mühlberger I, Husi H, Merseburger AS, Zoidakis J, Vlahou A, Schanstra JP, Mischak H, Jankowski V. Bhat A, et al. Among authors: merseburger as. PLoS One. 2015 Jan 8;10(1):e0116404. doi: 10.1371/journal.pone.0116404. eCollection 2015. PLoS One. 2015. PMID: 25569276 Free PMC article.
Development and Validation of Urine-based Peptide Biomarker Panels for Detecting Bladder Cancer in a Multi-center Study.
Frantzi M, van Kessel KE, Zwarthoff EC, Marquez M, Rava M, Malats N, Merseburger AS, Katafigiotis I, Stravodimos K, Mullen W, Zoidakis J, Makridakis M, Pejchinovski M, Critselis E, Lichtinghagen R, Brand K, Dakna M, Roubelakis MG, Theodorescu D, Vlahou A, Mischak H, Anagnou NP. Frantzi M, et al. Among authors: merseburger as. Clin Cancer Res. 2016 Aug 15;22(16):4077-86. doi: 10.1158/1078-0432.CCR-15-2715. Epub 2016 Mar 29. Clin Cancer Res. 2016. PMID: 27026199
Clinical Proteomics for Precision Medicine: The Bladder Cancer Case.
Latosinska A, Frantzi M, Vlahou A, Merseburger AS, Mischak H. Latosinska A, et al. Among authors: merseburger as. Proteomics Clin Appl. 2018 Mar;12(2). doi: 10.1002/prca.201700074. Epub 2017 Oct 25. Proteomics Clin Appl. 2018. PMID: 28980455 Review.
Proteomics analysis of bladder cancer invasion: Targeting EIF3D for therapeutic intervention.
Latosinska A, Mokou M, Makridakis M, Mullen W, Zoidakis J, Lygirou V, Frantzi M, Katafigiotis I, Stravodimos K, Hupe MC, Dobrzynski M, Kolch W, Merseburger AS, Mischak H, Roubelakis MG, Vlahou A. Latosinska A, et al. Among authors: merseburger as. Oncotarget. 2017 Apr 20;8(41):69435-69455. doi: 10.18632/oncotarget.17279. eCollection 2017 Sep 19. Oncotarget. 2017. PMID: 29050215 Free PMC article.
423 results